CI
ADN

Cowen Inc’s Advent Technologies ADN Stock Holding History

Cowen Inc’s Portfolio ADN Stock Details ADN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,798
Closed -$2.3M – 448
2019
Q1 		$2.3M Buy
+7,798
New +$2.29M 0.25% 72

Other funds holding ADN

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Cowen Inc's ADN Position: Q2 2019 in Review

Cowen Inc sold out of Advent Technologies (ADN) in Q2 2019, closing a stake of 7,798 shares — an estimated $2.3M sold.

Cowen Inc first reported a position in ADN in Q1 2019 and held it in 1 quarter. The position peaked at $2.3M in Q1 2019. 30 funds tracked by Wall St. Rank hold ADN as of Q2 2019.

  • Cowen Inc reported no remaining Advent Technologies position as of Q2 2019 after selling out during the quarter.
  • Cowen Inc sold 7,798 Advent Technologies shares in Q2 2019, an estimated $2.3M.
  • Cowen Inc first reported a position in Advent Technologies in Q1 2019 and held it in 1 quarter.
  • Cowen Inc's Advent Technologies position peaked at $2.3M in Q1 2019.
  • 30 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.